share_log

Keybanc Maintains Overweight on Steris, Raises Price Target to $254

Benzinga ·  Jul 25, 2023 04:11

Keybanc analyst Matthew Mishan maintains Steris (NYSE:STE) with a Overweight and raises the price target from $235 to $254.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment